Clinicopathologic Conference, Borrelia Miyamotoi Infection
NEJM 383:1578-1586, Case 32-2020, 2020
Bornavirus Encephalitis Shows a Characteristic Magnetic Resonance Phenotype in Humans
Ann Neurol 88:723-735, Finck, T.,et al, 2020
Sensory Ganglionopathy
NEJM 383:1657-1662, Amato, A.A. & Ropper, A.H., 2020
Recurrent Cerebral Ischemia During Pregnancies
Neurol 95:e2453-e2457, Bulwa, Z.,et al, 2020
Headache, Confusion, and Somnolence in a 27-Year-Old Woman
JAMA doi:10-1001/JAMA.2020.10167, Sastry, R.,et al, 2020
A 73-Year-Old Man with Recurrent Aphasia, Headaches, and Confusion
Neurol 95:e2595-e2599, Bose, G.,et al, 2020
Migraine
NEJM 383:1866-1876, Ashina, M., 2020
A 72-year-old Man with a Progressive Cognitive and Cerebellar Syndrome
Neurol 95:e2707-e2710, Lad, M. & Griffiths, T.D., 2020
Tumefactive Primary Central Nervous System Vasculitis:Imaging Findings of a Rare and Underrecognized Neuroinflammatory Disease
AJNR 41:2075-2081, Suthiphosuwan,S.,et al, 2020
Dural Defect Repair as Treatment for Refractory Headache From Cerebrospinal Fluid Leak
Neurol 95:e2831-e2833, Chan,T.L.H., et al, 2020
A case of COVID-19-associated pharyngeal-cervical-brachial variant of Guillain-Barre syndrome
Neurol 95:978-983, Liberatore, G.,et al, 2020
Migraine, hearing loss, and blurred vision in a young woman
Neurol 95:e2945-e2950, Sasikumar, S.,et al, 2020
Guillain-Barre Syndrome Associated with SARS-CoV-2
NEJM 382:2574-2576, Tuscano, G.,et al, 2020
Guillain-Barre Syndrome Associated with JEV Infection
NEJM 383:1188-1190, Wang, G.,et al, 2020
Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis
Neurol 95:e3012-e3025, Spatola, M.,et al, 2020
Complex Ataxia
Neurol 95:136-141, Abkur, T.,et al, 2020
Burning Pain in the Legs
NEJM 383:e18, Sacks, C.A., 2020
One-Year Sustained Efficacy of Erenumab in Episodic Migraine
Neurol 95:e469-e479, Goadsby, P.J.,et al, 2020
MR Target Sign in Cerebral Aspergillosis
Neurohospitalist doi:10.1177/1941874420929191, Finelli, P.F., 2020
Teleneurology
Pract Neurol 19:13, Gollomp, S. & Mathew, P.G., 2020
Cavernous Sinus Thrombosis
WebMD 2020, , 2020
Neuropathological Features of Covid-19
NEJM doi:10.1056/NEJMc2019373, Solomon, I.H.,et al, 2020
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Carotid-Cavernous Fistula Presenting with Bilateral Abducens Palsy
Stroke 51:e107-e110, Peng, T.J.,et al, 2020
A 22-Year-Old Man with Progressive Bilateral Visual Loss
Neurol 94:625-630, Yang, S.L.,et al, 2020
A Young Health Woman with Difficult-to-Wean Acute Ventilator Dependence
Neurol 94:e1340-e1343, Chandrashekhar, S.,et al, 2020
Blurred Vision
BMJ 368:m569, Zhou, S.,et al, 2020
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
When the Temporal Artery Biopsy is Negative
Neurologist 25:70-72, Ford, E. & Smith, J.H., 2020
Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19
JAMA Otolaryngology Head Neck Surg doi:10.1001/JAMAOTO.2020.0832, Elieyer, M.,et al, 2020
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
NEJM 382:e61-e63, Oxley, T.J., et al, 2020
GQ1b-Seronegative Miller Fisher Syndrome Associated with Pembrolizumab
J Neuro-Ophthal 39:394-396, Green, K.E.,et al, 2019
Clinicopathologic Conference, Lymphocytic Choriomeningitis Virus Infection
NEJM 381:2553-2560, Case Record 40-2019, 2019
Acute Vestibular Migraine Treatment with Noninvasive Vagus Nerve Stimulation
Neurol 93:e1715-e1719, Beh, S.C. & Friedman, D.I., 2019
Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019
Progressive Neurological Impairment and an Enhancing Brainstem Lesion in a Middle-Aged Man
JAMA Neurol 76:1397-1398, Gupta, S.,et al, 2019
Progressive Proximal Weakness in a 56-year-old Man with Bone Pain
Neurol 93:939-944, Torabi,T.,et al, 2019
Ubrogepant for the Treatment of Migraine
NEJM 381:2230-2241, Dodick, D.W.,et al, 2019
Acute Treatment of Migraine in Children and Adolescents
Neurol 93:487-499, Oskoui, M.,et al, 2019
Pharmacologic Treatment for Pediatric Migraine Prevention
Neurol 93:500-509, Oskoui, M.,et al, 2019
Fremanezumab versus Placebo for Migraine Prevention in Patients with Documented Failure to Up to Four Migraine Preventive Medication Classes (FOCUS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3� Trial
Lancet 394:1030-1040, Ferrari, M.D.,et al, 2019
A 68-year-old Man with Rapid Cognitive Decline
Neurol 93:315-318, Berth, S.H.,et al, 2019
RCVS2 Score and Diagnostic Approach for Reversible Cerebral Vasoconstriction Syndrome
Neurol 92:e639-e647, Rocha, E.A.,et al, 2019
The Interpeduncular Angle:A Practical and Objective Marker for the Detection and Diagnosis of Intracranial Hypotension on Brain MRI
AJNR 40:1299-1303, Wang,D.J.,et al, 2019
Case 27-2019:A 16-Year-Old Girl with Head Trauma During a Sailboat Race
CPC,Concussion,Benign Paroxysmal Positional Vertigo, Case 27-2019, NEJM 381:863-871, Iaccarino,M.A.,et al, 2019
Ehlers-Danlos Syndromes
BMJ 366:I4966, Ghali, N.,et al, 2019
Stridor in Multiple System Atrophy
Neurol 93:630-639, Cortelli, P.,et al, 2019
Failing to See Blood on Susceptibility-Weighted Imaging
Neurol 93:e1495-e1496, Graham, E.,et al, 2019
Reversible Cerebral Vasoconstriciton Syndrome
www.UptoDate.com, June, Singhal, A., 2019
Clinicopathologic Conference, Adenovirus Meningoencephalitis
NEJM 381:1459-1470, Case 31-2019, 2019